PYC Therapeutics eyes key RNA therapy clinical milestones by 2028
PYC Therapeutics is advancing RNA therapies for rare diseases, progressing multiple clinical programs. Efficacy data is expected in the next 18 months, with registrational studies targeted for 2028.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.